Bateman RJ, Li Y, McDade EM, Llibre-Guerra JJ, et al. Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial. Lancet Neurol 2025;24:316-330.
PMID: 40120616